黎巴嫩的药物基因组学:当前状况,挑战和机遇
Lorenzo Chidiac1, Hady Yazbeck1, Rami Mahfouz2
1Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
本研究评估了黎巴嫩的药物基因组学 (PGx) 研究,强调了由于遗传多样性的潜力. 它概述了目前的PGx实践,挑战和促进研究,教育和临床实施的机会.
科学领域:
- 药物基因组学 药物基因组学
- 遗传学 是一个遗传学.
- 临床医学 临床医学
背景情况:
- 黎巴嫩的人口表现出显著的遗传多样性,使药物基因组学 (PGx) 具有高度相关性.
- 该国已建立的医疗和教育基础设施使其能够推进PGx研究和应用.
- 需要对黎巴嫩现有的PGx研究和实践进行全面审查.
研究的目的:
- 评估目前在黎巴嫩的药物基因组学 (PGx) 研究格局.
- 描述PGx临床实践的现状,确定当地和地区的挑战.
- 突出推动PGx研究,教育和实施的机会和可行的步骤.
主要方法:
- 在黎巴嫩对现有药物基因组学 (PGx) 研究的文献审查和评估.
- 评估PGx实践的现状,包括挑战和机遇.
- 美国贝鲁特大学医学院和医学中心对PGx的案例研究分析.
主要成果:
- 该研究审查了现有的PGx研究,并评估了黎巴嫩目前的做法.
- 它确定了PGx实施和教育的挑战和机遇.
- 贝鲁特美国大学是开发综合PGx课程的典范.
结论:
- 黎巴嫩有很大的潜力为药物基因组学 (PGx) 研究和临床应用作出贡献.
- 应对挑战和利用机会可以推动PGx教育和实践在区域范围内.
- 开发综合的PGx计划对于黎巴嫩和该地区的个性化医疗至关重要.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
相关概念视频
Analysis of Population Pharmacokinetic Data
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
Drug Discovery: Overview
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
